[SRNE] QoQ Quarter Result on 30-Sep-2011 [#Q3]

Stock
[SRNE] Sorrento Therapeutics, Inc.
Announcement Date
08-Nov-2011
Financial Year
2011
Quarter
30-Sep-2011 [#Q3]
Profit Trend
QoQ- 35.48%
YoY- -57.75%
Quarter Report
SRNE's Result
SRNE's Financial Summary
View:
Show?
Quarter Result
30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 31/03/11 31/12/10 CAGR
Revenue 217 110 128 92 74 235 512 -43.60%
PBT -943 -906 -3,236 -445 -1,088 -684,443 -1,808 -35.23%
Tax 4 3 -2,474 2 3 1,644 -1,620 -
NP -943 -906 -762 -702 -1,088 -684 -188 193.31%
Tax Rate - - - - - - - -
Total Cost 1,160 1,016 890 794 1,162 920 700 40.07%
Ratio Analysis
30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 31/03/11 31/12/10 CAGR
NP Margin -434.35 -822.64 -595.84 -765.39 -1,466.69 -290.80 -36.75 419.64%
Per Share
30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 31/03/11 31/12/10 CAGR
EPS -0.08 -0.09 -0.07 -0.07 -0.11 -0.07 -0.02 152.19%
EPS Diluted -0.08 -0.09 -0.07 -0.07 -0.11 -0.07 -0.02 152.19%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.